Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | GLA | P06280 | 1/20 | 0.59 |
| ▸ | MYC | P01106 | 1/20 | 0.58 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.58 |
| ▸ | SORT1 | Q99523 | 9/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | METAP2 | P50579 | 1/20 | 0.47 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.47 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.47 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.47 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.47 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | GALR3 | O60755 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | CASP1 | P29466 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29571243 | 1.00 | KDM4E (0.59) | KDM4EGLAMYCNR4A1SORT1 | |
| SCHEMBL16050286 | 0.88 | ALDH1A1 (0.50) | KDM4EGLAMYCNR4A1SORT1 | |
| SCHEMBL27298440 | 0.83 | ALDH1A1 (0.57) | KDM4EGLAMYCNR4A1SORT1 | |
| SCHEMBL30753064 | 0.83 | KDM4E (0.53) | KDM4EGLAMYCNR4A1SORT1 | |
| SCHEMBL6360 | 0.83 | KDM4E (0.53) | KDM4EGLAMYCNR4A1SORT1 | |
| SCHEMBL30976481 | 0.83 | MAOA (0.50) | KDM4EGLAMYCNR4A1SORT1 | |
| SCHEMBL9353897 | 0.83 | MAOA (0.50) | KDM4EGLAMYCNR4A1SORT1 | |
| SCHEMBL31200433 | 0.81 | DGAT1 (0.55) | KDM4EGLAMYCNR4A1SORT1 | |
| SCHEMBL18431 | 0.81 | ALDH1A1 (0.46) | KDM4EGLAMYCNR4A1SORT1 | |
| SCHEMBL1788262 | 0.81 | DGAT1 (0.55) | KDM4EGLAMYCNR4A1SORT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 868 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119930421-A | Synthesis method of 5-bromo-2-methylbenzoic acid | 浙江天宇药业股份有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-118580180-A | Intermediate of EZH2 inhibitor, and preparation method and application thereof | 上海市第七人民医院 | 2024-09-03 | — | — | CN | claimed |
| CN-117105779-A | Preparation method of 5-bromo-2-formylbenzoic acid methyl ester | 河南师范大学 | 2023-11-24 | — | — | CN | claimed |
| CN-113527313-B | Preparation method and application of water-soluble supermolecule organic cage-shaped compound for detecting pyridinium substances in water | 浙江浙能技术研究院有限公司 | 2022-07-12 | — | — | CN | claimed |
| US-20220024950-A1 | METHOD FOR PREPARING BORIC ACID ESTER BASED ON LITHIUM COMPOUND | SOOCHOW UNIVERSITY (CN) | 2022-01-27 | — | — | US | claimed |
| CN-113527313-A | Preparation method and application of water-soluble supermolecule organic cage-shaped compound for detecting pyridinium substances in water | 浙江浙能技术研究院有限公司 | 2021-10-22 | — | — | CN | claimed |
| CN-113149828-A | Preparation method of 5-bromo-2-methylbenzoic acid | 山东寿光增瑞化工有限公司 | 2021-07-23 | — | — | CN | claimed |
| CN-109503641-B | Method for preparing borate ester based on anilino lithium compound | 苏州大学 | 2021-01-01 | — | — | CN | claimed |
| CN-109369696-B | Method for preparing alcohol compound by using anilino lithium compound as catalyst | 苏州大学 | 2021-01-01 | — | — | CN | claimed |
| CN-109438493-B | Method for preparing borate based on n-butyl lithium | 苏州大学 | 2020-09-08 | — | — | CN | claimed |
| WO-2020118922-A1 | METHOD FOR PREPARING BORIC ACID ESTER BASED ON LITHIUM COMPOUND | 苏州大学 | 2020-06-18 | — | — | WO | claimed |
| WO-2020113835-A1 | METHOD FOR PREPARING BORIC ACID ESTER USING UNCATALYZED HYDROBORATION OF CARBOXYLIC ACID | 苏州大学 | 2020-06-11 | — | — | WO | claimed |
| CN-104892566-A | Preparation method of 2-(5-bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene | SHANGHAI INST TECHNOLOGY | 2015-09-09 | — | — | CN | claimed |
| EP-0069810-B1 | NOVEL DIBENZOXEPINS, THEIR PREPARATION, COMPOSITIONS CONTAINING THEM AND THE USE OF DIBENZOXEPINS IN THE TREATMENT OF ALLERGIC CONDITIONS | MERCK & CO. INC. (US) | 1986-12-03 | — | — | EP | claimed |
| EP-0069810-A1 | Novel dibenzoxepins, their preparation, compositions containing them and the use of dibenzoxepins in the treatment of allergic conditions | MERCK & CO. INC. (US) | 1983-01-19 | — | — | EP | claimed |
| US-12612426-B2 | Aryl glucoside derivative | SHANGHAI ZHEYE BIOTECHNOLOGY CO. LTD. (CN) | 2026-04-28 | — | — | US | disclosed |
| US-12612427-B2 | Aryl glucoside derivative, preparation method therefor and application thereof | SHANGHAI ZHEYE BIOTECHNOLOGY CO. LTD. (CN) | 2026-04-28 | — | — | US | disclosed |
| EP-0069810-A1 | Novel dibenzoxepins, their preparation, compositions containing them and the use of dibenzoxepins in the treatment of allergic conditions | MERCK & CO. INC. (US) | 1983-01-19 | — | — | EP | disclosed |
| US-4282365-A | Dibenz[b,e]oxepin compounds | MERCK & CO., INC. (US) | 1981-08-04 | — | — | US | disclosed |
| US-3953595-A | Substituted benzoic acid hypolipemic agents | PFIZER INC. (US) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12612426-B2 | Aryl glucoside derivative | SLC5A1, SLC5A2, GPR119 | KDM4E 3750/4885GLA 1372/4885MYC 1419/4885 |
| US-12612427-B2 | Aryl glucoside derivative, preparation method therefor and application thereof | SLC5A1, SLC10A1, SLC5A2 | KDM4E 4429/4885GLA 1296/4885MYC 2201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.